As aesthetic medicine continues to converge with consumer skincare, few innovations are as compelling as dissolvable microneedle technology. The Needeep PDRN Renu Shot Kit by Juvic represents a serious attempt to translate clinical-grade transdermal delivery into a daily home-care routine — and the science behind it is worth a close look.
Device Research Product Formulation PDRN Microneedle K-BeautyAbout Juvic & the Needeep Brand
Juvic (주빅) is a Korean biotech company founded by PhD- and MD-level researchers from Yonsei University's Department of Life Science, specializing in microneedle science and transdermal drug delivery. The company holds over 90 SCI-indexed publications and more than 90 domestic and international patents, making it one of the most research-backed players in the K-beauty microneedle space.
Their consumer skincare brand, Needeep, was launched to bring proprietary MicroDeep™ technology directly to consumers — positioning the line as a bridge between clinical-grade procedures and evidence-based home care.
Needeep received the FIX 2025 Innovation Award (Future Innovation Tech Expo, Daegu) and was presented at IFSCC 2025 in France, one of the world's most prestigious cosmetic science conferences, where it received strong recognition from the global research community.
"Needeep is a solution where AI diagnoses skin conditions and recommends appropriate active ingredients, providing microneedle cosmetics containing those ingredients." — Juvic Research Director Kang Geon-woo, FIX 2025
The Device: MicroDeep™ Technology
At the core of the Renu Shot Kit is Juvic's proprietary MicroDeep™ platform — a dissolvable microneedle delivery system produced through low-temperature vacuum forming. The technology exists in two formats within the product:
Starcle™ Platform
A star-shaped microstructure that physically penetrates the stratum corneum — the outermost skin barrier that blocks most topical actives. Once inserted, the microneedle tips dissolve upon contact with interstitial skin fluid, releasing encapsulated actives directly into the viable epidermis. This bypasses the primary barrier to topical absorption without the pain or recovery associated with conventional microneedling devices.
Deep Cushion Platform
A porous cushion applicator that combines channeling (mechanical stimulation to create micro-pathways) with cushioning (press-and-release delivery of the ampoule). The cushion is coated with dissolvable PDRN-loaded MicroDeep™ tips, enabling the first step to both prep the skin and deliver actives simultaneously.
The Formulation: PDRN Science
PDRN (Polydeoxyribonucleotide) is a well-established bioactive derived from salmon or trout sperm DNA. Its clinical use has been documented primarily in injectable mesotherapy and wound healing, but its incorporation into topical delivery systems is relatively new — and dependent entirely on the quality of the delivery mechanism.
| Component | Function | Concentration |
|---|---|---|
| PDRN (Microneedle) | Cell turnover, tissue repair, collagen stimulation | 137,000 ppm |
| PDRN (Ampoule) | Elasticity improvement, regeneration | 132,800 ppm |
| 5× Hyaluronic Acid | Multi-depth hydration, barrier support | — |
| Peptides | Collagen synthesis, firmness | — |
| Glycosaminoglycans | Extracellular matrix support | — |
The PDRN concentration of 137,000 ppm in the microneedle component is among the highest I have seen in the home-care segment. Clinically, PDRN works via the A2A adenosine receptor pathway, stimulating tissue repair, reducing inflammation, and promoting angiogenesis — effects well-supported in peer-reviewed literature on injectable PDRN (Polydeoxyribonucleotide) preparations such as Placentex® and Plermin®.
The key scientific question with any topical PDRN product is whether sufficient intact DNA fragments reach the dermis at effective concentrations. This is precisely where the MicroDeep™ delivery system provides a meaningful advantage over conventional serums.
How It Works: The 2-Step Protocol
After cleansing and toning, press the cushion applicator across the face up to 50 times. The dissolvable microneedle tips create microchannels in the stratum corneum while simultaneously releasing PDRN into the skin. This step primes the skin for maximized uptake of the ampoule in Step 2.
Pump 2–3 doses of the PDRN ampoule into the cushion and press vertically across the face. The combination of pre-channeled skin and the cushioning motion delivers the high-concentration PDRN + peptide + hyaluronic acid complex deep into the viable epidermis. Finish with gentle rolling until absorbed.
Clinical Evidence & Safety
The kit has passed dermatological safety testing (hypoallergenic certification), making it suitable for sensitive skin types. Internal clinical preliminary assessments reported improvements in hydration, luminosity, and elasticity with single-use application — a reflection of the immediate film-forming and hydrating properties of high-concentration PDRN and hyaluronic acid complexes.
The formulation is fragrance-free, addressing a known irritation factor in previous iterations of the product. For individuals who cannot tolerate clinical PDRN procedures (e.g., Juran® injections) due to needle aversion, cost, or access limitations, this system offers a scientifically grounded alternative.
"The microneedle structure penetrates the skin and dissolves immediately upon contact with body fluids — enhancing delivery of active ingredients through the stratum corneum." — FIX 2025 Innovation Awards
Dr. June's Assessment
| Dimension | Evaluation |
|---|---|
| Delivery Technology | ★★★★★ — Patent-backed MicroDeep™ system is genuinely differentiated from spicule or topical-only approaches |
| Formulation Quality | ★★★★☆ — PDRN concentration is clinically relevant; multi-weight HA and peptides are well-chosen co-actives |
| Ease of Use | ★★★★☆ — 2-step protocol is intuitive; suitable for non-professional home use |
| Safety Profile | ★★★★★ — Fragrance-free, hypoallergenic certified, painless application |
| Clinical Backing | ★★★★☆ — Strong IP and academic pedigree; full independent RCT data would strengthen claims further |
The Needeep PDRN Renu Shot Kit sits at the intersection of transdermal drug delivery science and the rapidly evolving home-care technology space. For patients and consumers seeking clinical-grade skin improvement without in-clinic procedures, it represents one of the more scientifically credible options currently available. The combination of validated delivery technology, high active concentrations, and a clean, minimal formulation is commendable.
As microneedle home-care continues to mature as a category, I expect to see more independent clinical validation of these systems. Juvic's research output to date — particularly their published SCI work on microneedle architecture — provides a stronger foundation than most competitors in this space.
This review is based on publicly available product information, peer-reviewed literature on PDRN and microneedle technology, and independent evaluation. No commercial relationship with Juvic or Needeep.
← Back to Research